Lab literacy · Certificates

A “KLOW” certificate of analysis:
what it should show for each peptide

A certificate of analysis (COA) is useful only when its results identify what was tested and match the vial’s batch. For a vial listing four peptides, check for separate identity and amount results for each one.

Short answerLab literacy · 5 min read · Updated 21 Nov 2026

A useful “KLOW” certificate of analysis (COA) should identify and measure each of the four listed peptides: GHK-Cu, BPC-157, TB-500 and KPV. Its results need to match the vial’s batch number. A single identity result or purity percentage for the whole mixture cannot establish what each component is or how much is present.

Key takeaways

  • “KLOW” is a seller name for a vial listing GHK-Cu, BPC-157, TB-500 and KPV, not a single defined molecule.
  • Check that the COA names the same batch as the vial and reports results for each listed peptide separately.
  • An identity result and a purity result answer different questions; neither alone establishes the amount of every component.
  • A COA documents results for the sample tested, not every vial or every possible quality property.

01What a report for a four-peptide vial should show

There is no single COA layout used by every laboratory. The general checks for any report, and the order to run them in, are on how to read a COA; the rows below show what each field has to show for a vial that lists four peptides.

FieldWhat to check on a COA for a vial listing four peptides
Material name and formThe document names the tested material and identifies the chemical form where relevant. A name alone does not tell you that four separate components were tested.
Components testedLook for a separate line for GHK-Cu, BPC-157, TB-500 and KPV. The document should make clear which result belongs to which component.
Batch or lot numberCompare the number on the document with the number printed on the vial. If they differ, the document does not match that vial’s stated batch.
Sample and test datesLook for dates tied to the sample and laboratory work. A date by itself does not show which batch was tested.
Laboratory identityCheck that the laboratory is named and that the report identifies who authorized or reviewed it.
Test methodEach result should name its method. “Identity” or “purity” without a method leaves you unable to tell what the reported number represents.
Identity resultCheck for an identity result for each listed peptide, with the expected reference and observed result where the method reports them.
Purity and amount resultsLook for separate results for each component, and check whether the document distinguishes purity from measured peptide content. One total for the vial cannot show the split between its components.

For active pharmaceutical ingredients covered by FDA’s Q7A guidance, a certificate should identify the material and batch, list tests and acceptance limits with results, and be dated and signed. That guidance is not a universal template for every research-material document.

02What identity and purity results mean

Identity asks whether the sample’s analytical result is consistent with the named component. Mass spectrometry (MS) can report a measured mass for comparison with an expected value. The comparison only makes sense when the expected value matches the chemical form named on the document.

Listed componentExpected mass information in FDA’s 2026 briefingsWhat the COA should show
BPC-157Free base: 1419.5 g/molA separate identity result for BPC-157, with the relevant expected and observed values.
TB-500Free base: 889.01 g/molA separate identity result. Check that the chemical form stated on the COA matches the mass reference.
KPVFree base: 342.43 g/molA separate identity result for KPV, not a result attributed to the mixture as a whole.
GHK-CuThis page does not give a numeric reference mass.Look for a separate identity result that identifies GHK-Cu and its method.

These FDA values are for the named free-base forms; they are reference information, not test results for a KLOW vial. In one 2024 nomination FDA reviewed for another peptide, the certificate named the acetate salt while the nomination named the free base, and the certificate gave the free base’s formula and weight. That is why the form and identity result need to be read together.

Purity is also not the same as amount. A percentage labelled “purity” reports a result from the stated method; it does not, by itself, give the measured mass of each peptide in a mixed vial. In the same 2024 review, FDA described a supplier’s certificate that reports purity and peptide content as separate results. Read the labels on the results rather than treating one percentage as both.

03Match the report to the vial

Matching the lot is a document check, not evidence that every possible property was tested.

1
Read the vial’s lot number

Find the batch or lot identifier on the vial label. Do not substitute a product name for the lot number.

2
Find that number on the COA

Check the COA’s material name and lot field. If the identifiers do not match, the report does not document the batch named on the vial.

3
Trace each result to a component

Look for four component-specific identity results and four component-specific amount results, rather than one result for an undivided mixture.

4
Check method, date and reviewer

Confirm that each test names a method and that the document identifies when the analysis was performed and who reviewed or authorized it.

FDA’s Q7A guidance says that laboratory records identify the sample and batch, methods, data, results, acceptance criteria, and test and review dates or signatures. It also describes batch numbers as identifiers that can connect material to its production and distribution history. Those are useful checks on traceability; a matching number alone does not confirm a document’s authenticity.

For the broader checks that apply to any report, read how to read a COA.

04What a COA cannot tell you

A COA reports results from tests on a sample. It does not automatically show that every listed component was tested, that a reported percentage is the amount in the vial, or that the sample represents every vial associated with the batch. Read the named tests and results, not a general “pass” statement on its own.

One result

A single identity result does not establish the identities of four separately listed peptides.

One percentage

A total or purity percentage for a mixture cannot show the separate amount of each component.

One matching number

A matching lot number helps link the document and vial, but does not independently verify the test data or every quality property.

This page shows no result from any batch. A page about how to inspect the document does not establish what any particular vial contains.

RefSources

  1. U.S. Food and Drug Administration. Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients, sections 6.6 (laboratory control records), 11.4 (certificates of analysis) and 20 (glossary: batch number). Guidance for industry; read 21 Nov 2026. www.fda.gov/regulatory-information/search-fda-guidance-docum…
  2. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee briefing on BPC-157-related substances. Briefing document, July 2026. www.fda.gov/media/193343/download
  3. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee briefing on TB-500-related substances. Briefing document, July 2026. www.fda.gov/media/193349/download
  4. U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee briefing on KPV-related substances. Briefing document, July 2026. www.fda.gov/media/193346/download
  5. U.S. Food and Drug Administration. FDA briefing document, Pharmacy Compounding Advisory Committee meeting of 4 December 2024: AOD-9604-related bulk drug substances. Advisory committee briefing, 2024 (PDF pp. 9, 15); read 21 Nov 2026. www.fda.gov/media/183584/download

Plain-English summary of public sources, not legal or medical advice. Last checked 21 Nov 2026.

Questions

Does one purity percentage confirm all four components?

No. A single percentage does not show a separate identity and amount result for each listed peptide. Check which component and test method each result refers to.

Why compare the batch number on a COA with the one on the vial?

The lot number links the document to the batch it describes. If the numbers differ, the report does not match the batch named on the vial.

Is a matching lot number enough to verify a COA?

No. It is one traceability check. Also examine the laboratory identity, methods, component-specific results, dates, and document review or authorization.

Evidence before hype.

One email a week: new research explained and regulatory changes. No prices, no hype.

Get the 6:00 brief

Free. Unsubscribe any time.

Written by 6AM Research. Drafted from primary sources; every claim links to its source, and the page is dated. Editorial policy · How we check every page